NASDAQ:KYTH (KYTH) (KYTH) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free KYTH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range$0.09▼$0.0952-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (KYTH) alerts: Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About (KYTH) Stock (NASDAQ:KYTH)KYTHERA Biopharmaceuticals, Inc. (KYTHERA) is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of prescription products for the aesthetic medicine market. The Company's initial focus is on the facial aesthetics market. The Company's product candidate is ATX101, an injectable drug in late-stage clinical development for the treatment of submental fullness associated with submental fat, which commonly presents as an undesirable double chin. ATX101 is a formulation of a purified synthetic version of deoxycholic acid. The Company has completed Phase III clinical trials for ATX101 and has made regulatory filings outside the United States, in Canada, Switzerland and Australia.Read More Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him KYTH Stock News HeadlinesApril 4, 2024 | msn.comGlare from car headlights can be a killer – Scotsman commentApril 3, 2024 | msn.comCasino chips ‘stealthily’ disappear from Tropicana Las Vegas before final closureApril 25, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.April 3, 2024 | msn.comResilience in the Face of Adversity Taiwan’s Response to the Strong Earthquake and Tsunami ThreatMarch 27, 2024 | msn.comRebecca Kenna on testing two years on tour: 'It's helped me as a person and a player'March 26, 2024 | msn.comThe best asparagus you've ever made is topped with garlic and cheese. Here's how to make itJanuary 10, 2024 | morningstar.comAgro Capital Management Corp ACMBDecember 4, 2023 | msn.comXponential Fitness to acquire LindoraApril 25, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.December 4, 2023 | msn.comRCI Hospitality declares $0.06 dividendNovember 26, 2023 | msn.comBowl Projections: Huge favorite emerges as Tennessee’s destinationNovember 9, 2023 | morningstar.comeXp World Holdings Inc 44YSeptember 14, 2023 | msn.comPBA draft a rich harvestMay 13, 2023 | msn.comJust a fraud heads-up: I received a recorded message claiming to be from my bank’s fraud protection line.April 14, 2023 | msn.comScreaming people and bodies everywhere: The horrific aftermath of Myanmar junta airstrike that killed 165April 12, 2023 | msn.comScreaming people and bodies everywhere: The horrific aftermath of Myanmar junta airstrike that killed 133April 12, 2023 | msn.comScreaming people and bodies everywhere: The horrific aftermath of Myanmar junta airstrike that killed 100March 31, 2023 | msn.comBillionaire LeBron James REJECTS Elon Musk's $8 fee for a blue tickMarch 7, 2023 | msn.comMorocco, Credible Strategic Partner for France and EU (French MP)December 28, 2022 | msn.comWI Attorney General to focus fighting crime, ensuring public safety and protecting kids in 2023November 5, 2022 | msn.comAnimals dream too—here's what we knowOctober 9, 2022 | msn.comWorld Mental Health Day 2022: 81% school students anxious about studies and exam results, shows NCERT surveyOctober 8, 2022 | msn.comWoman and baby boy found dead in house in DublinSeptember 13, 2022 | msn.comAfternoon brief: Karnataka minister sets Bengaluru demolitions timeline and all the latest newsSeptember 1, 2022 | msn.comDA nominates three retired judges for Ramaphosa’s Phala Phala inquiryMarch 22, 2022 | msn.com2 teachers stabbed to death by student at Sweden schoolAugust 25, 2021 | msn.comSharing Chinese Herbal Soups and Teas, Steeped in TraditionSee More Headlines Receive KYTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (KYTH) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/06/2015Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryBiotechnology Current SymbolNASDAQ:KYTH CUSIP50157010 CIK1436304 WebN/A Phone+1-818-5874500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report KYTH Stock Analysis - Frequently Asked Questions How were (KYTH)'s earnings last quarter? (KYTH) (NASDAQ:KYTH) announced its earnings results on Thursday, August, 6th. The biopharmaceutical company reported ($1.44) earnings per share for the quarter, missing the consensus estimate of ($1.10) by $0.34. The biopharmaceutical company had revenue of $288 million for the quarter. What other stocks do shareholders of (KYTH) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (KYTH) investors own include Bausch Health Companies (BHC), Gilead Sciences (GILD), (RPTP) (RPTP), Altaba (AABA), Intercept Pharmaceuticals (ICPT), Incyte (INCY), NPS Pharmaceuticals (NPSP), OPKO Health (OPK) and Puma Biotechnology (PBYI). This page (NASDAQ:KYTH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (KYTH) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
